(S)-1-(3-(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)-8-(phenylamino)-9H-purin-9-yl)pyrrolidin-1-yl)prop-2-en-1-one

ID: ALA5202214

PubChem CID: 162356161

Max Phase: Preclinical

Molecular Formula: C29H33N9O

Molecular Weight: 523.65

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)N1CC[C@H](n2c(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)C1

Standard InChI:  InChI=1S/C29H33N9O/c1-3-26(39)37-14-13-24(20-37)38-27-25(33-29(38)32-21-7-5-4-6-8-21)19-30-28(34-27)31-22-9-11-23(12-10-22)36-17-15-35(2)16-18-36/h3-12,19,24H,1,13-18,20H2,2H3,(H,32,33)(H,30,31,34)/t24-/m0/s1

Standard InChI Key:  RGGHJDGRJJWIJE-DEOSSOPVSA-N

Molfile:  

 
     RDKit          2D

 39 44  0  0  0  0  0  0  0  0999 V2000
   -3.3746    0.1545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3757   -0.6704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6624   -1.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9474   -0.6699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9503    0.1581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6642    0.5681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6667    1.3908    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9548    1.8022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2427    1.3926    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2527    3.0380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9610    2.6208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6626   -1.8986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3716   -2.3077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3718   -3.1262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6630   -3.5356    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6632   -4.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9540   -3.1266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9539   -2.3080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5334    2.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5291    1.8039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2547    1.5537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    2.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2478    2.8852    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5535    2.2263    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5117    0.7765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0386    0.1112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5231   -0.5484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3003   -0.2914    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2959    0.5270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9591    2.9373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9650   -0.7690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8837   -1.5835    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7110   -0.4322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3757   -0.9098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7778    2.9363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1833    3.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7703    4.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9476    4.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5458    3.6365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
 10 11  2  0
 11  8  1  0
  3 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 12 18  1  0
 17 18  1  0
 19 10  1  0
  9 20  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 19  1  0
 22 24  1  0
 25 21  1  6
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 25  1  0
 24 30  1  0
 28 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  2  0
 30 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5202214

    ---

Associated Targets(Human)

EGFR Tclin VHL/EGFR (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 523.65Molecular Weight (Monoisotopic): 523.2808AlogP: 4.02#Rotatable Bonds: 7
Polar Surface Area: 94.45Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.96CX LogP: 4.08CX LogD: 3.41
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -1.18

References

1. Zhao HY, Wang HP, Mao YZ, Zhang H, Xin M, Xi XX, Lei H, Mao S, Li DH, Zhang SQ..  (2022)  Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands.,  65  (6.0): [PMID:35254067] [10.1021/acs.jmedchem.1c01827]

Source